Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

  • This share is currently suspended. It was suspended at a price of 0.225

Share Price Information for Kanabo Grp Plc (KNB)

Share Price is delayed by 15 minutes
Get Live Data
0.225    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.42m
KNB Live PriceLast checked at - London Stock Exchange

Intraday Kanabo Grp Plc Share Chart

Director/PDMR Shareholding

28 Aug 2024 14:31

RNS Number : 0358C
Kanabo Group PLC
28 August 2024
 

28/08/2024

Kanabo Group Plc

("Kanabo" or the "Company")

 

Director/PDMR Dealing

 

Kanabo Group Plc (LSE:KNB  leading health tech company, is pleased to announces that Ian Mattioli, Non Executive Director and Chairperson, has purchased 150,000 ordinary shares at a price of £0.0123. Following the share purchase, Ian Mattioli's beneficial interests in the capital of the Company is 2.85%.

In addition, Suleman Sacranie, chief Technology Officer and founder of the GP Service, has purchased 75,187 ordinary shares at a price of £0.0133. Following the purchase of shares Suleman Sacranie holds 11,420,861 ordinary shares representing 1.81% of the issued share capital of the Company.

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

--ENDS-

 

For further information, please visit http://www.kanabogroup.com/ or contact the following:

Kanabo Group Plc

via Peterhouse Capital

Tel: +44 (0)20 7469 0930

Avihu Tamir, CEO

Peterhouse Capital Ltd (Financial Adviser & Broker)

Tel: +44 (0)20 7469 0930

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 Ian Mattioli

 

2

 

Reason for the notification

 Purchase of shares

a)

 

Position/status

 

 

PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

 

a)

 

Name

 

 

Kanabo Group Plc

b)

 

LEI

 

 

213800XPJFSNWJIYKN52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5 pence each in Kanabo Group Plc

Identification code

GB00BYQCS703

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.23p

150,000

d)

 

Aggregated information

- Aggregated volume

18,011,111.00

- Price

1.25p

e)

 

Date of the transaction

 

 

27.08.2024

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Suleman Sacranie

 

2

 

Reason for the notification

 Purchase of shares

a)

 

Position/status

 

 

PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

 

a)

 

Name

 

 

Kanabo Group Plc

b)

 

LEI

 

 

213800XPJFSNWJIYKN52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5 pence each in Kanabo Group Plc

Identification code

GB00BYQCS703

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.33p

75,187

d)

 

Aggregated information

- Aggregated volume

11,420,861.00

- Price

1.25p

e)

 

Date of the transaction

 

 

27.08.2024

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKFBNNBKDKFB
Date   Source Headline
11th Dec 202511:30 amRNSDisposal of Subsidiary: The GP Service Limited
28th Nov 20254:02 pmRNSAppointment of Joint Administrators
1st May 20257:30 amRNSSuspension - Kanabo Group plc
30th Apr 20252:47 pmRNSTemporary suspension of listing
4th Apr 20254:20 pmRNSBusiness Update
24th Mar 202511:02 amRNSResignation of Director
4th Mar 20257:00 amRNSRevenue Growth, Trading and Operational Update
6th Jan 20257:00 amRNSDirectorate Change
31st Oct 20249:48 amRNSCorrection Director/PDMR Shareholding
29th Oct 202411:39 amRNSDirector/PDMR Shareholding
30th Sep 20242:50 pmRNSHalf-year Report
28th Aug 20242:31 pmRNSDirector/PDMR Shareholding
27th Jun 20244:49 pmRNSResult of AGM
4th Jun 20247:00 amRNSExpansion:14 New Clinics Partnership with Treat-It
31st May 202410:30 amRNSNotice of AGM
30th Apr 20242:15 pmRNSAnnual Financial Report
28th Mar 20247:00 amRNSExpansion of Treat It to Mental Health Treatments
27th Mar 20245:11 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSGermany Medical Cannabis Legislation Reform
18th Mar 20249:14 amRNSAgritec Update
15th Jan 20247:00 amRNSPartnership to launch a Walk-In Pain Clinic
14th Nov 20237:00 amRNSContract Extension With Major UK Retailer
2nd Nov 20237:00 amRNSPartnership with BRITISH CANNABISâ„¢
29th Sep 20237:00 amRNSHalf-Year Results
31st Aug 202311:13 amRNSTotal Voting Rights
11th Aug 202311:36 amRNSIssuance of New Ordinary Shares and TVR
26th Jul 20232:00 pmRNSAdmission and Total Voting Rights
24th Jul 20234:10 pmRNSIssuance of New Ordinary Shares and TVR
17th Jul 20237:00 amRNSSuccess for Kanabo Agritec with Contract Award
10th Jul 202311:19 amRNSIssue of New Ordinary Shares and TVR
30th Jun 20232:34 pmRNSResult of AGM
28th Jun 20237:00 amRNSIssue of New Ordinary Shares and TVR
23rd Jun 20237:00 amRNSGrant of Options
13th Jun 20232:39 pmRNSPublication of a Prospectus
8th Jun 20235:19 pmRNSNotice of Annual General Meeting
31st May 202311:30 amRNSTotal Voting Rights
26th May 202310:30 amRNSTotal Voting Rights
23rd May 202311:00 amRNSIssuance of New Ordinary Shares
16th May 20233:00 pmRNSUpdate: Amendments to Acquisition Agreement
16th May 20237:00 amRNSAmendments to Acquisition Agreement
15th May 20237:00 amRNSTotal Voting Rights
12th May 20237:00 amRNSTotal Voting Rights
10th May 20232:52 pmRNSResult of Broker Option
9th May 20237:00 amRNSAppointment of Ian Mattioli as Non-Executive Chair
9th May 20237:00 amRNSFundraise of £2.54 million and Broker Option
4th May 20234:45 pmRNSBoard Change
2nd May 20237:00 amRNSFull Year Results 2022
31st Mar 20232:40 pmRNSDirectorate Change
13th Mar 20237:00 amRNSTreat It Launch: Online Medicinal Cannabis Clinic
7th Mar 202312:15 pmRNSAppointment of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.